| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/16/2012 | CA2808251A1 Neuroprotective and neuro-restorative iron chelators and monoamine oxidase inhibitors and uses thereof |
| 02/16/2012 | CA2808061A1 Hepatitis c virus inhibitors |
| 02/16/2012 | CA2808039A1 Prophylactic or therapeutic agent for non-alcoholic steatohepatitis |
| 02/16/2012 | CA2808016A1 Novel 6,7-disubstituted-isoquinoline derivatives and their use |
| 02/16/2012 | CA2807971A1 Heteroaryls and uses thereof |
| 02/16/2012 | CA2807947A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity |
| 02/16/2012 | CA2807872A1 Derivatives of 6,7-dihydro-3h-oxazolo [3,4-a] pyrazine-5,8-dione |
| 02/16/2012 | CA2807858A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 02/16/2012 | CA2807855A1 4-[-2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine hydrochloride amorphous solid forms |
| 02/16/2012 | CA2807687A1 6-cycloalkyl-1, 5-dihydro-pyrazolo (3,4-d) pyrimidin-4-one derivatives and their use as pde9a inhibitors |
| 02/16/2012 | CA2807661A1 Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease |
| 02/16/2012 | CA2807634A1 Inhibitors of bruton's tyrosine kinase |
| 02/16/2012 | CA2807616A1 Methods and compositions for preventing a condition |
| 02/16/2012 | CA2807546A1 Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| 02/16/2012 | CA2807538A1 Novel trpv3 modulators |
| 02/16/2012 | CA2807484A1 Methods for extending progression-free survival using 10-propargyl-10-deazaaminopterin |
| 02/16/2012 | CA2807460A1 Heterocyclic compound and use thereof |
| 02/16/2012 | CA2807359A1 Inhibitor of casein kinase 1.delta. and casein kinase 1.epsilon. |
| 02/16/2012 | CA2807136A1 Antisense antiviral compounds and methods for treating a filovirus infection |
| 02/16/2012 | CA2807082A1 Crystalline form of pyrimidio[6,1-a]isoquinolin-4-one compound |
| 02/16/2012 | CA2807051A1 Besylate salt of a btk inhibitor |
| 02/16/2012 | CA2807034A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
| 02/16/2012 | CA2806658A1 Tetraline and indane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806646A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806644A1 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806643A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 02/16/2012 | CA2806614A1 Combinatory cancer treatment |
| 02/16/2012 | CA2806547A1 Heterocyclic antiviral compounds |
| 02/16/2012 | CA2806459A1 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| 02/16/2012 | CA2806447A1 Neuropilin as a biomarker for bevacizumab combination therapies |
| 02/16/2012 | CA2806324A1 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof |
| 02/16/2012 | CA2806159A1 New azacyclic compounds |
| 02/16/2012 | CA2806154A1 Panthenyl docosahexaeneoate and its use for treating and preventing cardiovascular diseases |
| 02/16/2012 | CA2805974A1 Use of binders for manufacturing storage stable formulations |
| 02/16/2012 | CA2805867A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds |
| 02/16/2012 | CA2804749A1 Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists |
| 02/16/2012 | CA2803656A1 Combination of glyt1 compound with antipsychotics |
| 02/16/2012 | CA2783017A1 Synthetic bile acid compositions and methods |
| 02/15/2012 | EP2418279A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 02/15/2012 | EP2418212A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 02/15/2012 | EP2418211A1 Deuterated morphinane compounds |
| 02/15/2012 | EP2418210A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 02/15/2012 | EP2418209A1 Aurora kinase modulators and method of use |
| 02/15/2012 | EP2418208A1 Inhibitor for elevation of gip level |
| 02/15/2012 | EP2418207A1 Sulfone compounds which modulate the CB2 receptor |
| 02/15/2012 | EP2418206A2 Benzodiazepine derivatives useful in the treatment of autoimmune disorders |
| 02/15/2012 | EP2418205A1 Pyrimidine urea derivatives as kinase inhibitors |
| 02/15/2012 | EP2418203A1 Cyclic compound having substituted phenyl group |
| 02/15/2012 | EP2418202A1 New compounds |
| 02/15/2012 | EP2418201A1 Polymorph forms of (2S) - (4E) -N-methyl-5- (3-isopropoxypyridin) yl]-4-penten-2-amine for the treatment of central nervous system disorders |
| 02/15/2012 | EP2418200A1 Phthalimide derivatives of non-steroidal anti-inflammatory compounds and/or tnf- modulators, method for producing same, pharmaceutical compositions containing same and uses thereof for the treatment of inflammatory diseases |
| 02/15/2012 | EP2418196A1 Dual alanyl-aminopeptidase and dipeptidyl-peptidase IV inhibitors |
| 02/15/2012 | EP2418191A1 Long-chain trimethoxyphenylalkanol derivatives, and pharmaceuticals comprising the same |
| 02/15/2012 | EP2417986A1 Bioactive compositions |
| 02/15/2012 | EP2417985A1 Mitochondrial function-improving agent |
| 02/15/2012 | EP2417979A1 Beneficial effects of increasing local blood flow |
| 02/15/2012 | EP2417978A1 Beneficial effects of increasing local blood flow |
| 02/15/2012 | EP2417976A1 Process for production of orally ingestible composition containing arabinosyl vitexin, and use of the composition |
| 02/15/2012 | EP2417975A1 Fulvestrant nanosphere/microsphere and preparative method and use thereof |
| 02/15/2012 | EP2417974A1 Combination therapy for treatment of immune disorders |
| 02/15/2012 | EP2417973A1 SUSTAINED RELEASE COMPOSITION CONTAINING TETRAHYDROPYRIDO Ý4, 3-b¨INDOLE DERIVATIVE AND PREPARATION METHOD OF DERIVATIVE |
| 02/15/2012 | EP2417972A2 Pharmaceutical composition for treating or preventing burn injuries |
| 02/15/2012 | EP2417971A1 Clomiphene for use in increasing the chances of pregnancy of women having a low ovarian reserve |
| 02/15/2012 | EP2417970A2 Coenzyme q10 nanoparticles, preparation method thereof and composition containing said nanoparticles |
| 02/15/2012 | EP2417943A1 Drug-delivery endovascular stent and method for treating restenosis |
| 02/15/2012 | EP2417446A1 A method of characterizing phytochemicals from trigonella foenum graceum |
| 02/15/2012 | EP2417267A1 Method of treatment based on polymorphisms of the kcnq1 gene |
| 02/15/2012 | EP2417257A1 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease |
| 02/15/2012 | EP2417249A1 Dna-cell conjugates |
| 02/15/2012 | EP2417148A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group |
| 02/15/2012 | EP2417146A1 (2 ' -deoxy-ribofuranosyl) -1,3,4, 7-tetrahydro- (1,3) iazepin-2-0ne derivatives for treating cancer |
| 02/15/2012 | EP2417145A1 6"-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides |
| 02/15/2012 | EP2417141A1 2-hydroxyethyl-1h-quinolin-2-one derivatives and their azaisosteric analogues with antibacterial activity |
| 02/15/2012 | EP2417140A1 Inhibitors of hiv replication |
| 02/15/2012 | EP2417138A1 Pyrazolo [1, 5-a] pyrimidine derivatives as mtor inhibitors |
| 02/15/2012 | EP2417136A1 Imidaz0ý1,2-a¨pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture |
| 02/15/2012 | EP2417135A1 Substituted triazolopyridines and analogs thereof |
| 02/15/2012 | EP2417133A1 Compounds and methods for antiviral treatment |
| 02/15/2012 | EP2417131A1 Isoxazol-3(2h)-one analogs as therapeutic agents |
| 02/15/2012 | EP2417130A2 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof |
| 02/15/2012 | EP2417129A1 Triazine-aryl-bis-indoles and process for preparation thereof |
| 02/15/2012 | EP2417127A1 Kinase inhibitors and method of treating cancer with same |
| 02/15/2012 | EP2417125A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors |
| 02/15/2012 | EP2417124A2 Serotonin and norepinephrine reuptake inhibitor |
| 02/15/2012 | EP2417123A2 Therapeutic compositions and related methods of use |
| 02/15/2012 | EP2417122A1 Indole derivatives and methods for antiviral treatment |
| 02/15/2012 | EP2417121A1 4, 5-dihydro-1h-pyrazole compounds and their pharmaceutical uses |
| 02/15/2012 | EP2417120A1 Substituted piperidines as ccr3 antagonists |
| 02/15/2012 | EP2417115A1 Inhibitors of fatty acid amide hydrolase |
| 02/15/2012 | EP2417112A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof |
| 02/15/2012 | EP2417111A1 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same |
| 02/15/2012 | EP2417110A2 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4]non-1-en-4-one (irbesartan) |
| 02/15/2012 | EP2417108A1 Organic compounds and their uses |
| 02/15/2012 | EP2417107A1 Crystal forms of saxagliptin |
| 02/15/2012 | EP2417106A1 Process for preparing pyrrolidinium salts |
| 02/15/2012 | EP2416801A1 Immunogenic composition and uses thereof |
| 02/15/2012 | EP2416795A1 Inhibitors of cognitive decline |
| 02/15/2012 | EP2416794A1 Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (hiv) or hepatitis c |
| 02/15/2012 | EP2416793A1 A plant extract comprising statins and preparation techniques and uses thereof |
| 02/15/2012 | EP2416792A2 Novel anti-aging agents and methods to identify them |